Anavex Life Sciences Corp (AVXL)

[jmvho]

Batermere - Our share price/market cap is an interesting topic. Basparks posted recently about how can the $2.41 billion market cap of AXON ( more than 10x our $235 million market cap ) be justified , and frankly I agree with him. If you look at the 52 week data that AXON presented in November compared to the 57 week data AVXL presented in December, there is no comparison. AXON's presentation is extremely light on data ( 2 slides as I recall ) and the end result shows it maybe extends the effect of the Donepezil by a couple of months but then the same downward trajectory on the graph continues. I would encourage you to compare them if you haven't already.

So, I personally think our share price is being artificially suppressed, either by the market manipulators working for the six million shares that are short or by an interested BP player that hopes to acquires us at the lowest price possible.